# "Treatment of Active HBV With γδT Cells" Clinical Trial Protocol

> **NCT03113058** · EARLY_PHASE1 · UNKNOWN · sponsor: **Jinan University Guangzhou** · enrollment: 60 (estimated)

## Conditions studied

- Adoptive Treatment for Hepatitis B With γδT Cells

## Interventions

- **COMBINATION_PRODUCT:** Adoptive transfer of γδT cells

## Key facts

- **NCT ID:** NCT03113058
- **Lead sponsor:** Jinan University Guangzhou
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-02
- **Primary completion:** 2018-10-05
- **Final completion:** 2018-11-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113058, ""Treatment of Active HBV With γδT Cells" Clinical Trial Protocol". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03113058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*